We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
–
AUM
$4.05B
AUM Growth
+$38.8M
Cap. Flow
-$116M
Cap. Flow %
-2.87%
Top 10 Hldgs %
18.39%
Holding
733
New
60
Increased
226
Reduced
298
Closed
60

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$27.2M
2
AMZN icon
Amazon
AMZN
+$19.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.8M
4
EAT icon
Brinker International
EAT
+$15.8M
5
APD icon
Air Products & Chemicals
APD
+$15.1M

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$24.7M
2
DIS icon
Walt Disney
DIS
+$19.9M
3
TGT icon
Target
TGT
+$19M
4
DRI icon
Darden Restaurants
DRI
+$18.6M
5
CI icon
Cigna
CI
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.77%
2 Technology 14.35%
3 Financials 11.2%
4 Industrials 10.03%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHY icon
526
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$323K 0.01%
3,800
-2,300
-38% -$196K
YUM icon
527
Yum! Brands
YUM
$42.5B
$322K 0.01%
4,926
– –
FE icon
528
FirstEnergy
FE
$28.1B
$316K 0.01%
9,539
-150
-2% -$5.1K
SJM icon
529
J.M. Smucker
SJM
$12.9B
$313K 0.01%
2,310
-1,260
-35% -$185K
PZA icon
530
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.22B
$310K 0.01%
11,900
-2,000
-14% -$52.5K
DBE icon
531
Invesco DB Energy Fund
DBE
$91.1M
$304K 0.01%
24,581
-1,214
-5% -$14.4K
LHCG
532
DELISTED
LHC Group LLC
LHCG
$304K 0.01%
8,234
-120,765
-94% -$4.84M
AMPH icon
533
Amphastar Pharmaceuticals
AMPH
$882M
$302K 0.01%
+15,905
New +$289K
INCY icon
534
Incyte
INCY
$24.2B
$302K 0.01%
3,200
– –
LVS icon
535
Las Vegas Sands
LVS
$31.7B
$302K 0.01%
+5,245
New +$270K
EPD icon
536
Enterprise Products Partners
EPD
$81.7B
$299K 0.01%
10,820
– –
TIP icon
537
iShares TIPS Bond ETF
TIP
$14.5B
$299K 0.01%
2,570
-345
-12% -$40K
NTRS icon
538
Northern Trust
NTRS
$22.4B
$289K 0.01%
4,255
-510
-11% -$34.6K
RIO icon
539
Rio Tinto
RIO
$158B
$285K 0.01%
8,530
+40
+0.5% +$1.27K
FITB
540
Fifth Third Bancorp
FITB
$51.1B
$283K 0.01%
13,850
– –
BHBK
541
DELISTED
Blue Hills Bancorp, Inc.
BHBK
$281K 0.01%
18,680
+1,195
+7% +$17.4K
ROK icon
542
Rockwell Automation
ROK
$52.7B
$280K 0.01%
+2,285
New +$267K
AET
543
DELISTED
Aetna Inc
AET
$278K 0.01%
2,406
– –
UN
544
DELISTED
Unilever NV New York Registry Shares
UN
$277K 0.01%
6,000
– –
SWBI icon
545
Smith & Wesson
SWBI
$653M
$271K 0.01%
13,270
– –
VGK icon
546
Vanguard FTSE Europe ETF
VGK
$30.7B
$268K 0.01%
5,491
– –
CPB icon
547
Campbell Soup
CPB
$6.55B
$265K 0.01%
4,850
-207,490
-98% -$12.6M
GL icon
548
Globe Life
GL
$14.1B
$264K 0.01%
4,125
– –
IWP icon
549
iShares Russell Mid-Cap Growth ETF
IWP
$19.7B
$262K 0.01%
+5,374
New +$261K
IFX
550
DELISTED
INFINEON TECH AG ADS(REP1 ORD)
IFX
$261K 0.01%
14,620
+40
+0.3% +$714
20 21
22
23 24

Similar funds

GVI
Green Valley Investors Wilmington, Delaware $1.76B AUM 5.64% 1-Year Est. Return
GMI
Greystone Managed Investments Regina, Saskatchewan, Canada $1.65B AUM 7.9% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
AWM
Ashmore Wealth Management Wilmington, Delaware $1.58B AUM 9.28% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Boston Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Boston Advisors held 733 positions worth $4.05B, up 0.97% from $4.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Advisors's Q3 2016 filing shows 60 new, 226 increased, 298 reduced and 60 closed positions. Its largest new stake was Vertex Pharmaceuticals: 188,245 shares worth $16.4M. The largest sale was Clorox, an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q3 2016 buy was Vertex Pharmaceuticals: 188,245 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q3 2016, an estimated $27.2M increase.
  • Boston Advisors's biggest Q3 2016 reduction was Clorox, cutting an estimated $24.7M.
  • Boston Advisors fully exited Cadence Design Systems in Q3 2016, selling an estimated $14.4M.
  • Boston Advisors's ten largest holdings make up 18% of its $4.05B portfolio in Q3 2016.
  • Boston Advisors opened 60 new positions and closed 60 in Q3 2016.
  • Boston Advisors's portfolio value rose 0.97% quarter-over-quarter to $4.05B.

Based on Boston Advisors's 13F filing for Q3 2016, filed 25 Oct 2016.